Pre-screening vs. screening: Understanding the differences in patient recruitment
Comprehensive pre-screening is often overlooked in favor of keeping participant pools as large as possible for longer periods of time. Here’s why that’s very often a mistake and how it impacts your bottom line.
Decentralized Clinical Trials: Why pharma companies are going digital
What are some common challenges the healthcare industry is up against as a whole? And how exactly does decentralization improve patient retention and reduce trial costs?
Why customized patient outreach leads to accelerated enrollment
By understanding your target audience, you can create a more meaningful and engaging experience that drives recruitment and fills your clinical trial faster than you thought possible.
Back to basics: Everything you need to know about patient recruitment for clinical trials
Only 1 in 10 drug development projects make it all the way from Phase I to approval. Why is that number so low, and are there any patient enrollment solutions for the pharmaceutical industry as a whole?
